Systems, methods, and computer-readable media for enabling ultraviolet radiation treatments are provided.

The present invention relates to a device for applying medical and cosmetic radiation to a human body or to parts thereof. Said radiation is preferably optical radiation. The device according to the invention comprises at least one first illuminant for producing the medical and cosmetic radiation. The device also comprises a first air flow for cooling an illuminant and a second air flow for cooling the human body or parts thereof. The device comprises at least one air-conditioning system, which is fluidically connected to the second air flow and designed for the air-conditioning treatment of the air flow. The device is characterized in that the device also has at least one disinfecting chamber, which is fluidically connected to the second air flow and is designed to physically disinfect the second air flow. The invention also relates to a method for operating such a device and to a corresponding disinfecting chamber.

The present invention relates to a device for applying energy to a human body. The device comprises a contact surface which defines an application region in which a human body can be placed in the effective range of the energy. The device further comprises at least one means for outputting the energy directed substantially onto the application region, and at least one means for generating a vapour mixture comprising at least one cannabinoid. The device according to the invention also comprises at least one means for guiding the vapour mixture, which has an effective dose of at least one cannabinoid, into the surroundings of the breathing orifices of a human body. The present invention further relates to a method for operating such a device, and to the use of vapour mixtures comprising at least one cannabinoid in designated devices.

Disclosed are embodiments of a method for affecting thrombi formation on an indwelling catheter. The method involves the step of providing an intravenous catheter. The intravenous catheter includes an inner surface and an outer surface, and the intravenous catheter is located within a blood vessel. A light diffusing element is inserted into the intravenous catheter. Light is emitted from the light diffusing element such that the light irradiates the intravenous catheter. The light emitted from the light diffusing element is configured to promote or hinder thrombi formation on the inner surface or outer surface of the intravenous catheter. Also disclosed are an illumination system for affecting thrombi formation on an intravenous catheter as well as an indwelling intravenous catheter system.

A surgical site infection management lighting system and method that utilizes Far Ultraviolet C radiation that is safely used to eliminate or reduce surgical site infections. An integrated visible lighting system that includes far ultraviolet radiation doses that are safe for human cell exposure and patient and medical practitioner because of the designed and engineered and computer programmed for pathogen destruction at low doses. The lighting and electromagnetic radiation system provides illumination and for high visibility which provides medical staff optimal vision while performing a surgical or medical procedure. The system further uses electromagnetic radiation frequency of 1.489-1.350 PHz and other frequencies that are pre-engineering and computer programmed for each electromagnetic radiation event during a surgical or medical procedure. The system will efficiently and safely keep all doses substantially low and safe for human exposure while effectively killing and destroying pathogens.

A method of corneal implantation with cross-linking is disclosed herein. In one or more embodiments, the method includes the steps of: (i) prior to implantation, treating an implant formed from donor corneal tissue or a tissue culture grown corneal stroma with a solution of sodium dodecyl sulfate (SDS), Triton X-100, benzalkonium chloride (BAK), Igepal, genipin, 100% glycerol, or alcohol for making the implant acellular, and for killing any bacteria, viruses, or parasites prior to implantation; (ii) implanting the implant into a recipient cornea; (iii) applying laser energy to the implant so as to modify the refractive power of the implant while being monitored using a Shack-Hartmann wavefront system so as to achieve a desired refractive power for the implant; and (iv) applying a cross-linking solution and irradiating the implant to cross-link the implant to prevent an immune response to the implant and/or rejection of the implant by a patient.

Products, compositions, systems, and methods for modifying a target structure which mediates or is associated with a biological activity, including treatment of conditions, disorders, or diseases mediated by or associated with a target structure, such as a virus, cell, subcellular structure or extracellular structure. The methods may be performed in situ in a non-invasive manner by application of an initiation energy to a subject thus producing an effect on or change to the target structure directly or via a modulation agent. The methods may further be performed by application of an initiation energy to a subject in situ to activate a pharmaceutical agent directly or via an energy modulation agent, optionally in the presence of one or more plasmonics active agents, thus producing an effect on or change to the target structure. Kits containing products or compositions formulated or configured and systems for use in practicing these methods.

In one aspect, embodiments relate to a system for preventative dental laser treatment that ensures even irradiation of a laser beam. The system includes, a laser arrangement configured to generate the laser beam. The laser beam has one or more of a super-Gaussian energy profile and a transverse ring mode. The system also includes a focus optic. The focus optic is configured to converge the laser beam with a numerical aperture of 0.1 or less to a focal region. The system also includes a hand piece configured to direct the laser beam at a surface of a dental hard tissue. The system additionally includes a controller. The controller is configured to control one or more parameters of the laser source, such that a portion of the surface of the dental hard tissue is heated to a temperature in a range between 400° Celsius and 1300° Celsius.

Provided is a mouthpiece which is mounted in an oral cavity for use in changing the shape of the skull including the maxillary bone and is composed of a plurality of segment pieces, at least some of the segment pieces being configured to approach or be spaced apart from each other by means of a screw, wherein the surfaces of the segment pieces facing or contacting the skin in the oral cavity are configured such that the segment pieces overlap with each other, such that a gap does not occur in spite of the approaching or spacing-apart movement of the segment pieces relative to each other.

The present disclosure relates to systems, methods, and uses of systems treating a skin condition with phototherapy. A system comprises (a) a phototherapy device comprising a phototherapy light source; (b) a patient computing device comprising a processor and a memory, the patient computing device configured to: transmit a first signal to the phototherapy device enabling operation of the phototherapy device according to one or more conditional prescription parameters, activate the phototherapy light source, and transmit a second signal reporting operation of the phototherapy device; and (c) a server configured to communicate with the patient computing device and receive the second signal. Also disclosed are systems, methods and compositions for controlling phototherapy treatments of the skin comprising (a) incorporating sun exposure into a prescribed phototherapy treatment; (b) quantitative measurement of erythema using digital image processing; (c) computer aided guidance for administration of targeted phototherapy; (d) treatment recommendations from outcome based analytics of a population of connected phototherapy devices; (e) an emollient with UV fading dye to visibly identify treated areas in the administration of targeted phototherapy.